UK Early Access to Medicines Scheme (EAMS)

Regulatory Framework

UK Medicines and Healthcare products Regulatory Agency (MHRA) guidance

Eligibility Criteria

Life-threatening or seriously debilitating condition; significant unmet medical need; medicinal product likely to offer major advantage over existing treatments; positive benefit-risk profile; advanced stage of development

Available Drugs (0)

No drugs linked to this program.